SAP180 and RBP1 are novel CDK substrates regulating the tumour suppressor pRb

Project Description

This project explores one group of molecules that cause cancer cells to grow uncontrollably. This research may lead to the development of new drugs against these molecules to inhibit cancer cell growth.

Final Lay Report

SAP180 and RBP1 are novel CDK substrates regulating the tumour suppressor pRb

Year

2008-2010

Researchers

Dr Borislav Sarcevic

Funding Body

Cancer Council Research Grant

Institution

St Vincent's Institute of Medical Research

Funding

$100,000 per annum

Updated: